Healthcare Hyperspectral Imaging (HSI) Systems Market to Record a CAGR of 16.41%, North America to Contribute Majority of Market Growth - Technavio
NEW YORK, Aug. 19, 2022 /PRNewswire/ -- The healthcare hyperspectral imaging (HSI) systems market will be driven by the increasing awareness coupled with safety and ease of use of systems. However, factors such as high investment and installation costs may challenge market growth.
The healthcare hyperspectral imaging (HSI) systems market size is expected to grow by USD 163.84 mn from 2020 to 2025. In addition, the growth momentum of the market will accelerate at a CAGR of 16.41% during the forecast period, according to Technavio.
Healthcare Hyperspectral Imaging (HSI) Systems Market 2021-2025:Vendor Analysis
The healthcare hyperspectral imaging (HSI) systems market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market. Applied Infrared Sensing, BaySpec Inc., Corning Inc., Galileo Group Inc., Gooch and Housego Plc, Headwall Photonics Inc., imec VZW, Konica Minolta Inc., Norsk Elektro Optikk AS, and Resonon Inc. are some of the major market participants. The key offerings of a few of these vendors are listed below:
Applied Infrared Sensing - The company offers a wide range of hyperspectral systems such as Airborne hyperspectral imaging systems, benchtop hyperspectral imaging systems among others.
BaySpec Inc. - The company offers a wide range of hyperspectral systems such as OCF-F Hyperspectral imager, GoldenEye Snapshot hyperspectral imager, among others.
Corning Inc. - The company offers a wide range of hyperspectral systems such as microHSI series.
Galileo Group Inc. - The company offers a wide range of hyperspectral systems such as AISA Eagle hyperspectral imaging sensor and AISA Hawk hyperspectral imaging sensor.
Gooch and Housego Plc - The company offers a wide range of hyperspectral systems such as HSi 300 hyperspectral imaging system.
Healthcare Hyperspectral Imaging (HSI) Systems Market 2021-2025:Segmentation
Product
Healthcare HSI Cameras: The healthcare HSI cameras segment will contribute the highest market share growth during the forecast period. Healthcare hyperspectral cameras can capture, collect, and display information from across the electromagnetic spectrum beyond visible light. Advances in medical imaging are incorporated into healthcare hyperspectral cameras.
Accessories
Geography
North America: This region will account for 40% of the market's growth during the forecast period. The growth of the region is attributed to factors such as increasing awareness, coupled with safety and ease of use. However, market growth in this region will be slower than the growth of the market in regions. The US is the key country for the healthcare hyperspectral imaging (HSI) systems market in North America.
Europe
Asia
ROW
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
Healthcare Hyperspectral Imaging (HSI) Systems Market 2021-2025:Key Highlights
CAGR of the market during the forecast period 2021-2025
Detailed information on factors that will assist healthcare hyperspectral imaging (HSI) systems market growth during the next five years
Estimation of the healthcare hyperspectral imaging (HSI) systems market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the healthcare hyperspectral imaging (HSI) systems market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of healthcare hyperspectral imaging (HSI) systems market vendors
Healthcare Hyperspectral Imaging (HSI) Systems Market Scope
Report Coverage
Details
Page number
120
Base year
2020
Forecast period
2021-2025
Growth momentum & CAGR
Accelerate at a CAGR of 16.41%
Market growth 2021-2025
USD 163.84 million
Market structure
Fragmented
YoY growth (%)
18.97
Regional analysis
North America, Europe, Asia, and ROW
Performing market contribution
North America at 40%
Key consumer countries
US, Germany, China, France, and UK
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
Applied Infrared Sensing, BaySpec Inc., Corning Inc., Galileo Group Inc., Gooch and Housego Plc, Headwall Photonics Inc., imec VZW, Konica Minolta Inc., Norsk Elektro Optikk AS, and Resonon Inc.
Market Dynamics
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Exhibit 53: Galileo Group Inc. - Product and service
Exhibit 54: Galileo Group Inc. - Key offerings
10.7 Gooch and Housego Plc
10.8 Headwall Photonics Inc.
Exhibit 59: Headwall Photonics Inc. - Overview
Exhibit 60: Headwall Photonics Inc. - Product and service
Exhibit 61: Headwall Photonics Inc. - Key news
Exhibit 62: Headwall Photonics Inc. - Key offerings
10.9 imec VZW
Exhibit 63: imec VZW - Overview
Exhibit 64: imec VZW - Product and service
Exhibit 65: imec VZW - Key news
Exhibit 66: imec VZW - Key offerings
10.10 Konica Minolta Inc.
Exhibit 67: Konica Minolta Inc. - Overview
Exhibit 68: Konica Minolta Inc. - Business segments
Exhibit 69: Konica Minolta Inc. - Key news
Exhibit 70: Konica Minolta Inc. - Key offerings
Exhibit 71: Konica Minolta Inc. - Segment focus
10.11 Norsk Elektro Optikk AS
Exhibit 72: Norsk Elektro Optikk AS - Overview
Exhibit 73: Norsk Elektro Optikk AS - Product and service
Exhibit 74: Norsk Elektro Optikk AS - Key offerings
10.12 Resonon Inc.
Exhibit 75: Resonon Inc. - Overview
Exhibit 76: Resonon Inc. - Product and service
Exhibit 77: Resonon Inc. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Currency conversion rates for US$
Exhibit 78: Currency conversion rates for US$
11.3 Research methodology
Exhibit 79: Research Methodology
Exhibit 80: Validation techniques employed for market sizing
Exhibit 81: Information sources
11.4 List of abbreviations
Exhibit 82: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse's...
Seed Health, a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer. An award-winning physician-scientist, Dr. Kassam has played a pivotal role in the advancement of microbiome science for...
bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced David Elzi, Ph.D., has been named Vice President of...
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the availability of Over the Counter ("OTC") Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, following Abbreviated New Drug Application ("ANDA") approval from the...
BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a collaboration with Janssen Biotech Inc., a Johnson & Johnson company. This strategic...
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces consistent favorable safety, tolerability, and efficacy from follow-up visits of the first cohort of three patients enrolled in the Company's Deltacel-01 Phase 1 clinical trial....